ORIGINAL RESEARCH ARTICLE ORIGINAL RESEARCH ARTICLE BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) represents approximately half of heart failure, and its incidence continues to increase. The leading cause of mortality in HFpEF is sudden death, but little is known about the underlying mechanisms.
H
eart disease is the leading cause of death in the United States, with coronary artery disease and heart failure (HF) the leading contributing conditions. 1 Disability and frequent hospitalizations are hallmarks of the disease. [2] [3] [4] Most of the diagnostic and therapeutic advances in the last 2 decades have been primarily in HF with reduced ejection fraction (HFrEF), which has been classically seen as the most common type of HF. 2, 3 The diastolic counterpart, HF with preserved ejection fraction (HFpEF), has been steadily increasing as a result of an aging population with frequent hypertension and obesity, such that HFpEF now accounts for approximately half (39-72%) of all HF. [5] [6] [7] Abnormal cardiac relaxation is a hallmark of HFpEF, but the underlying mechanisms remain unclear. 6, 8 Sudden cardiac death (SCD) is the most common cause of death in HF, making up ≈50% of the deaths in HFrEF and ≈25% in HFpEF. [9] [10] [11] [12] [13] Most SCD in patients with HF is likely secondary to ventricular arrhythmias (VA), although this conjecture is more secure for HFrEF than for HFpEF. 9, 10, 13 Action potential prolongation, downregulation of outward potassium currents, and altered calcium handling are important contributors to HFrEF-related VA, 9, 10, [13] [14] [15] [16] but little is known about the electrophysiological features of HFpEF. 9, 10, 13, 14, 17 Unlike HFrEF, for which numerous pharmacological and devicebased treatment options are available, no treatments have proven to be effective in improving survival in patients afflicted with HFpEF. [18] [19] [20] Here, we implemented a rodent model of HFpEF to investigate the incidence and underlying mechanisms of VA in HFpEF using in vivo, ex vivo, and single-cell electrophysiology studies.
METHODS

Animal Model of HFpEF
All animal experiments were approved by the Cedars-Sinai Institutional Animal Care and Use Committee. A Dahl saltsensitive (DSS) rat model of HFpEF was implemented as described [21] [22] [23] and as shown schematically in Figure 1A . In brief, male 7-week-old DSS rats (Charles River Laboratories, MA) underwent baseline transthoracic echocardiography and were then randomly assigned to a high-salt (HS) diet (AIN-76A plus 8% NaCl with irradiation, Research Diets) to induce HFpEF (n=38) 21, 22 or to a normal-salt (NS) diet (AIN-76A [0.3% NaCl] with irradiation) as controls (n=13). Feeding was continued ad libitum until rats reached the experimental end points at 14 to 18 weeks of age. Transthoracic echocardiogram was repeated to measure systolic and diastolic function at 14 and 18 weeks. Most HS-fed rats showed signs of HF, including weakness, decreased activity, cachexia, labored breathing, and body edema beginning at 14 weeks of age. Symptomatic HS rats demonstrating diastolic dysfunction (and preserved systolic function) by echocardiography were diagnosed with HFpEF. HS rats that failed to meet these criteria (≈20% of cases) were euthanized and omitted from analysis.
Transthoracic Echocardiogram
Rats were anesthetized with 5% isoflurane (induction) and maintained with 2% isoflurane for transthoracic echocardiography (Vevo 770, VisualSonics, Toronto, Canada). Systolic function was evaluated by calculating ejection fraction (percent) from images obtained in the parasternal short-axis view as described. 24 Diastolic function was assessed from the apical 4-chamber view by measuring E/A and E/E' ratios. [21] [22] [23] [24] E wave (early filling) and A wave (atrial filling) were measured by pulse-wave Doppler mode between the tips of the mitral valve. [21] [22] [23] [24] E' and A' waves were measured with tissue Doppler mode at the septal corner of the mitral annulus (the junction between the anterior mitral leaflet and ventricular septum). 24 Three separate measurements from each animal were averaged to quantify systolic and diastolic function.
Surface ECG
Surface ECG was recorded before in vivo arrhythmia-induction studies for HFpEF and control rats at 14 and 18 weeks (Dual Bio Amps, AD Instruments, Dunedin, New Zealand). PR interval, QRS duration, QT interval, and RR interval were measured 3 times and averaged by LabChart 7 software (AD Instruments). Corrected QT (QTc) interval was calculated as QT interval (milliseconds) divided by the square root of RR interval (seconds).
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In Vivo Arrhythmia-Induction Study Animals were anesthetized with 5% isoflurane (induction), intubated, and placed on mechanical ventilation as described. 26 Anesthesia was maintained with 2% isoflurane during programmed electric stimulation (PES). Core body temperature was monitored with a rectal probe and maintained at 36°C to 38°C via a heating lamp. ECG was monitored during the procedure (Dual Bio Amps). Under general anesthesia, a minithoracotomy was performed to expose the apex of the heart. After opening of the pericardial sac,
Clinical Perspective
What Is New?
• Delayed repolarization underlies increased arrhythmogenesis in rats with heart failure and preserved ejection fraction.
• Multiple reentry circuits resulting from action potential prolongation and dispersion contribute to the increased arrhythmogenesis.
• Downregulation of potassium currents (I to , I Kr , and I K1 ) is responsible for the action potential prolongation.
What Are the Clinical Implications?
• Abnormal repolarization, as reflected by QT interval prolongation, may play a mechanistic role in heart failure with preserved ejection fraction-associated sudden death.
• Action potential prolongation and increased fibrosis are logical therapeutic targets to decrease arrhythmic risk in patients with heart failure and preserved ejection fraction. A, Dahl salt-sensitive rats were fed a high-salt (HS; n=38) or normal-salt (NS; n=13) diet at 7 weeks of age after baseline echocardiography for ejection fraction (EF) as a systolic parameter and E/A and E/E' ratios as diastolic markers. Repeat echocardiogram was performed at 14 weeks of age. For control and heart failure with preserved EF (HFpEF) rats 14 to 18 weeks of age, we performed programmed electric stimulation (PES), electrocardiographic analysis, optical mapping, patch clamp, reverse-transcriptase polymerase chain reaction (PCR), and Western blot. B, EF was equivalent at baseline (7 weeks) in NS and HS rats (n=13 and 38, respectively), and it did not differ in follow-up in the various groups (n=13 and 38, respectively, at 14 weeks; n=7 and 5, respectively, at 18 weeks). C, Representative pulse-wave Doppler showing E (early filling) and A (atrial filling) wave changes and tissue Doppler describing E' and A' wave changes in NS and HS rats at 14 and 18 weeks of age. D, Baseline E/A ratios did not differ between NS and HS rats; however, by 14 weeks, the E/A ratio in HS rats decreased. At 18 weeks, the E/A ratio in HS rats pseudonormalized. E, The E/E' ratio increased in HS-fed rats at 14 weeks and continued to increase at 18 weeks. F, A normal value of E/A ratio was obtained from NS rats at 14 weeks of age (1.30-1.80 a platinum electrode was placed in the apex of the left ventricle. PES was performed with an electronic stimulator (PowerLab, AD Instruments) to apply a standard PES protocol. [27] [28] [29] [30] A drivetrain of 10 stimuli of S1 (5 V, 1-millisecond pulse width, and 100-millisecond interval) was delivered, followed by an extrastimulus (S2; 5 V and 1-millisecond pulse width) starting at a coupling interval of 80 milliseconds and by 1-millisecond decrements until the effective refractory period was reached. If ventricular tachycardia or fibrillation was not induced, a second extrastimulus (S3) was introduced from 80 milliseconds at progressively decreasing coupling intervals until the effective refractory period was reached. Finally, a third extrastimulus (S4) was introduced from an 80-millisecond coupling interval until the effective refractory period was reached. If the rat failed to develop VA with 3 extrastimuli (S1-S2-S3-S4), the animal was deemed noninducible. In rats that developed VA during PES, the protocol was repeated to confirm the reproducibility of the arrhythmia. To quantify the inducibility of VA, we created and implemented an arrhythmogenicity index (AI) defined by the following equation: [(number of VA beats) + (last extrastimulus coupling interval {miliseconds} -40)] / [square root of (numer of extrastimuli)].
This index takes into account not only the duration of the arrhythmia (in number of beats) but also the aggressiveness of the PES protocol, thus allowing a more accurate quantification of arrhythmia inducibility in both groups. Cesium chloride (Cs) and magnesium sulfate (Mg) were administered as follows: Cs (10 mL of 1 mmol/L) was delivered through tail vein to prolong QTc interval and to provoke VA. Mg (1 mL of 100 mg, 0.83 mol/L) also was delivered through tail vein to suppress VA in HFpEF rats. NS5806 (1 mL of 1 mmol/L, Sigma-Aldrich, St. Louis, MO) was delivered through tail vein to shorten QTc by activating the transient outward potassium current in HFpEF rats.
Ex Vivo Optical Mapping
For ex vivo optical mapping experiments, rats were anesthetized with 5% isoflurane, the chest was opened, and the heart was harvested as described. [31] [32] [33] The ascending aorta was cannulated and retrogradely perfused in a Langendorff system with Tyrode's solution containing 1.8 mmol/L CaCl 2 at 10 mL/min. RH237 (Molecular Probes) was used to index membrane potential changes (0.05 mg in 50 mL Tyrode solution for 5 minutes). Blebbistatin (Sigma-Aldrich) was used to as an uncoupler to avoid motion artifacts (0.5 mg in 100 mL Tyrode solution perfusion for 10 minutes, 0.017 mmol/L). Images were acquired with an MiCAM05 Ultima-L CMOS camera (SciMedia) with filters (excitation, 520/35 nm; dichroic, 560 nm; emission, 715 nm long pass) and stored for offline analysis. BV-Ana software (SciMedia) was used to calculate action potential duration (APD) at 90% (APD90) and visualized the reentry circuits after ex vivo PES.
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Isolation of Cardiomyocytes
Adult ventricular cardiomyocytes were isolated as described. 38 In brief, heparin (4000 IU per 1 kg) was injected intraperitoneally 1 hour before the heart was excised. Rats were euthanized, and the heart was rapidly removed after thoracotomy. After 
Action Potential Recordings
Action potentials were recorded in HFpEF and control cardiomyocytes. For action potential recordings, we placed the isolated cardiomyocytes in an experimental chamber (0. A 100-millisecond prepulse to −40 mV from a holding potential of −80 mV was used to inactivate Na + current and nifedipine (20 µmol/L) to block L-type Ca current. Outward potassium currents were evoked by voltage steps to potentials from −60 to 60 mV in 10-mV increments lasting 3000 milliseconds. Series resistance compensation (40-70%) was used. Membrane currents sampled at 5 kHz were filtered at 2 kHz. I to amplitude was measured as the difference between the peak outward current and the current at the end of the pulse. 39, 40 Current density (pA/pF) was calculated from the current amplitude (pA) divided by the membrane capacitance (pF).
Rapid Component of Delayed Rectifier Potassium Current
The rapid component of the delayed rectifier (I Kr ) was measured in control and HFpEF rats. The external and pipette solutions were the same as used to record I to , with nifedipine (20 µmol/L) added to block L-type Ca current. After a 100-millisecond prepulse to −40 mV to inactivate Na + channels, I Kr was evoked by voltage steps to potentials from −60 to 60 mV in 10-mV increments lasting 3000 milliseconds. I Kr was defined as E-4031-sensitive current. E-4031 (1 μmol/L, Sigma-Aldrich) was applied, and currents were subtracted.
Inward Rectifier Potassium Current
Inward rectifier potassium current (I K1 ) was measured in control and HFpEF cardiomyocytes. The external and pipette solutions were the same as I to , with nifedipine (20 µmol/L) added to block L-type Ca current. After a 100-millisecond prepulse to −40 mV to inactivate Na + channels, I K1 was evoked by voltage steps to potentials from −120 to 10 mV in 10-mV increments lasting 500 milliseconds. Barium (100 μmol/L) was then added to the external solution; I K1 was defined as bariumsensitive current.
L-Type Calcium Current
L-type calcium current (I CaL ) was measured in control and HFpEF cardiomyocytes. 
Quantitative Reverse-Transcriptase Polymerase Chain Reaction
Heart tissue was stored in Allprotect Tissue Reagent (Qiagen, Hilden, Germany) for quantitative reverse-transcriptase polymerase chain reaction. Total RNA was isolated from heart tissue with RNeasy Plus Universal Mini Kit (Qiagen). cDNA was synthesized with 2 µg RNA with the High Capacity RNA-to-cDNA Kit (Applied Biosystems). Primers were obtained from Abcam (Cambridge, UK) (Scn5a, Cacna1c, Cacna1d, Kcnd2, Kcnd3, Kcna4, Kcna5, Kcnh2, Kcnq1, Kcnj2 and Ldha). Quantitative reverse-transcriptase polymerase chain reaction was performed using TaqMan Universal Master Mix II with Uracil-N Glycosylase (Applied Biosystems, MA) under the following conditions: 50°C for 2 minutes (Uracil-N Glycosylase incubation), 95°C for 10 minutes (polymerase activation), and 40 cycles of 95°C for 15 seconds (denaturation) and 60°C for 1 minute (annealing and extension). Each cycle threshold (CT) value was normalized to the CT value of lactate dehydrogenase A (Ldha). Fold change was calculated with 2^(−ddCT) compared with the control group. Log scale of fold change was used to compare expression levels.
Protein Isolation and Western Blot
Protein was extracted from heart tissue with Tissue Ruptor (Qiagen) with radioimmunoprecipitation assay buffer and protease inhibitor (Thermo Fisher Scientific). Protein quantification was performed with Bradford Protein Assay (Bio-Rad). Western blot was performed with the NuPAGE system (4-12% Bis-Tris gradient gel, 2-morpholinoethane SDS running buffer, transfer buffer, and TBS Tween buffer; Life Technologies). Kv4.2, Kv4.3, Kv1.4, Kv11.1, Kir2.1, and GAPDH antibodies were obtained from Abcam (Kv4.2-ab16719, Kv4.3-ab99045, Kv1.4-ab16718, Kv11.1-ab92513, Kir2.1-ab109750, GAPDH-ab9483). Primary antibody (1:1000) was incubated overnight with 5% BSA at 4°C, and secondary antibody (horseradish peroxidase conjugated, 1:20 000) was incubated for 90 minutes with 5% BSA at room temperature. Immunoreactivity was detected by enhanced chemiluminescent substrate (Thermo Fisher Scientific).
Masson's Trichrome Staining
Midventricular heart tissues were cut and stained according to the manufacturer's protocol (Sigma-Aldrich). Fractional myocardial fibrosis (blue-gray pixels divided by total pixels) was measured with ImageJ software.
Statistical Analysis
Continuous variables are shown as mean±SD, and categorical variables are presented as percentages. Normal distribution was assessed with the Kolmogorov-Smirnov test, and homogeneity of variance was tested by the Levene test. The Student t test (paired or unpaired as appropriate) was used for the comparison of variables with normal distribution, and the Wilcoxon rank-sum test was used for the comparisons of nonnormally distributed variables. Analysis of repeated measures was performed with mixed-model regression to adjust for any possible missing data points with post hoc testing across groups adjusted for multiple testing (Tukey). The Fisher exact test was used to compare categorical variables (arrhythmia induction rates). Multiple t tests of quantitative reverse-transcriptase polymerase chain reaction data across groups were performed with step-down bootstrap sampling to control the familywise error rate at 0.05. A 2-tailed P value was used to assess statistical significance. SAS version 9.4 software (SAS Institute Inc.) was used for analysis.
RESULTS
Development of HFpEF in HS-Fed Rats
Figure 1B through 1E shows echocardiographic data at 7, 14, and 18 weeks of age. EF was equivalent at baseline (7 weeks) in NS and HS rats, and it did not differ in follow-up in the various groups ( Figure 1B) . Figure 1C shows representative E-and A-wave changes from pulse-wave Doppler mode and E'-and A'-wave changes in tissue Doppler mode at 7, 14, and 18 weeks of age. Pooled data reveal that baseline E/A ratios did not differ between NS and HS rats; however, by 14 weeks, the E/A ratio in HS rats decreased (1.25±0.24 versus 1.56±0.13 in NS; P<0.001), verifying the development of diastolic dysfunction ( Figure 1D ). At 18 weeks, the E/A ratio in HS rats approached values in NS rats (1.46±0.17 versus 1.60±0.08; P=0.27), consistent with pseudonormalization of the E/A ratio as seen in the progression of diastolic dysfunction 22, 41 ( Figure 1D ). Although no differences in E/E' ratio were seen at 7 weeks, E/E' increased in HS rats at 14 and 18 weeks (P=0.011 at 14 weeks and P<0.001 at 18 weeks; Figure 1E) . Unlike the E/A ratio, E/E' rises monotonically as diastolic dysfunction progresses 42 and is thus helpful in differentiating salutary from pseudonormal changes in E/A ratio ( Figure 1C) . To define the normal range for diastolic function, we plotted 95% distribution values (2.5-97.5%) of the E/A ratio and E/E' ratio of 13 NS rats at 14 weeks of age ( Figure 1F and 1G) , which yielded normal E/A of 1.30 to 1.80 and 9.86 to 17.19 for E/E'. Diastolic dysfunction was defined as either an E/A ratio <1.30 or an E/E' ratio >17.19 ( Figure 1F and 1G). Of 38 HS rats, 31 were verified to have diastolic dysfunction. Such rats showed signs of HF such as weakness, decreased activity, labored breathing, or body edema starting from 14 weeks of age and thus were classified as having not only diastolic dysfunction but also HFpEF.
Increased Susceptibility to VA in HFpEF Rats
PES was performed in vivo in control (n=13) and HFpEF (n=31) rats at 14 to 16 weeks. In control animals, VAs were induced in only 3 of 13 rats (23.1%) after PES (Movie I in the online-only Data Supplement, no induction of arrhythmia in a control rat). In contrast, VAs were induced in 27 of 31 HFpEF rats (87.1%). The VAs were monomorphic in 7 of 27 inducible HFpEF rats, but most (20 of 27, 74%) showed polymorphic ventricular tachycardia (VT) or ventricular fibrillation ( Figure 2A and 2B and Movie II in the online-only Data Supplement, induction of polymorphic VT in an HFpEF rat). Not only was the propensity to develop VT/ventricular fibrillation after PES higher in HFpEF animals (P<0.001), but also they were easier to induce by PES compared with controls ( Figure 2C ). The duration of induced VA was longer in HFpEF rats compared with controls ( Figure 2D ). We defined AI as a single parameter that takes into account the duration of the arrhythmias and the aggressiveness of the PES protocol; this number was markedly increased in HFpEF rats (30.1±20.0 versus 3.9±8.1 in controls; P<0.001; Figure 2E ). A, Representative surface electrograms (top, stimuli; bottom, ECG) show no inducible arrhythmias in a control rat with S1, S2, S3, and S4 stimuli. B, Polymorphic ventricular tachycardia (VT) in an HFpEF rat induced by S1, S2, S3, and S4 stimuli. C, PES in 13 control and 31 HFpEF rats showed increased susceptibility to ventricular arrhythmias (VAs) in HFpEF rats. D, HFpEF rats exhibited more prolonged VA compared with control rats. E, Arrhythmogenicity index (AI) was increased in HFpEF rats compared with control rats. Control rats, n=13; and HFpEF rats, n=31. Pooled data lines show mean and SD. VF indicates ventricular fibrillation. **P<0.001. Fisher exact test was used in C, and Wilcoxon rank-sum test was used in E.
ORIGINAL RESEARCH ARTICLE
ECG Analyses in Control and HFpEF Rats
By surface ECG, no conduction delays were evident in HFpEF animals at 14 or 18 weeks relative to controls (PR interval data in Figure 3A , QRS interval in Figure 3B ). However, repolarization (as manifested by QT and QTc interval) was prolonged in HFpEF rats, as evident from the representative ECGs in Figure 3C through 3E. Pooled data confirm QT increases at 14 weeks (111.1±18.0 versus 81.8±5.9 milliseconds in controls; P<0.001) and even more so with progression of the disease at 18 weeks (126.5±10.1 versus 88.5±8.1 milliseconds in controls; P<0.001; Figure 3D Figure 3E ). However, heart rate (reported here by RR interval) was not different among groups ( Figure 3F ). The observed QTc prolongation prompted us to question whether repolarization reserve might be decreased in HFpEF. We tested this prediction by infusing Cs, a nonselective potassium channel blocker, intravenously at a final concentration of 1 mmol/L (10 mL) and Mg (100 mg in 1 mL) to counter the effects. Figure 4A and 4B shows typical results. Cs increased the tendency to VA inducibility, whereas Mg suppressed VA. Overall, Cs prolonged QTc in HFpEF rats (P=0.011) and increased AI (P=0.047; Figure 4C ), whereas Mg abbreviated QTc (P=0.039) and markedly decreased AI (P=0.007; Figure 4D ). Control rats exhibited a trend toward QTc prolongation after Cs administration (192.0±7-213.6±15 milliseconds; P=0.069), but VAs were not induced ( Figure 4E ).
Optical Mapping in LangendorffPerfused Hearts
During ex vivo perfusion of isolated hearts, optical mapping revealed action potentials evoked by pacing at 100-, 200-, and 300-millisecond cycle length. Figure 5A and 5B shows representative action potential recordings in control and HFpEF rat hearts at 300-millisecond cycle length. Restitution curve shows APD90 prolongation in HFpEF rats (142.8±12.4 versus 97.3±4.5 milliseconds in controls; P=0.002) at 300-millisecond cycle length and at 200-millisecond cycle length (115.0±8.3 versus 83.0±5.6 milliseconds in controls; P=0.003; Figure 5C ). In HFpEF rats, APD was widely dispersed and heterogeneous compared with controls (SD of APD90, 11.1±2.0 versus 4.0±1.2; P=0.001; Figure 5D and 5E). In addition, ex vivo PES demonstrated inducible VT/ventricular fibrillation in HFpEF hearts ( Figure 5F ). Analysis of the activation patterns showed both clockwise and counterclockwise conduction in the left ventricle, suggesting multiple reentry circuits as the arrhythmia mechanism ( Figure 5G ment, multiple reentry circuits). The site of block (first beat of VT in Figure 5G ) was found to be located in the region where the APD dispersion was high (APD map in Figure 5F ), and this created the first reentry circuit for the arrhythmia, which can implicate the importance of APD dispersion as the functional reentry mechanism.
Single-Cell Electrophysiology
Action potentials were longer in HFpEF cardiomyocytes than in controls, as is evident from the representative records superimposed in Figure 6A . Such differences were consistent; Figure 6B shows that APD90 was prolonged in Figure 6C ), consistent with previous observations. 21 Given the observed delay of repolarization, we quantified the density of the transient outward potassium current (I to ), which is the ma- ORIGINAL RESEARCH ARTICLE jor repolarizing current in rodent hearts. 43 Compared with cardiomyocytes from control animals, I to was decreased in cardiomyocytes from HFpEF rats (4.13±1.78 versus 8.03±3.75 pA/pF in controls at 60 mV; P<0.05; Figure 6D and 6E). Reductions in I to have been documented in multiple models of HFrEF but not previously in HFpEF. The rapid component of delayed rectifier potassium current (I Kr ) was also decreased in HFpEF rats (0.92±0.52 versus 2.46±1.28 pA/pF in controls at 60 mV; P<0.05; Figure 6F and 6G). However, because of the relatively low density of the current, the contribution of I Kr to the repolarization duration will be smaller than that of I to . The inward rectifier potassium current (I K1 ) was also revealed to be downregulated in HFpEF rats (−7.58±4.90 versus −16.81±5.50 pA/pF in controls at −120 mV; P<0.05; Figure 6H and 6I). However, the changes are smaller in the physiological range (−70 to 10 mV). In contrast to the prevailing downregulation of K currents, L-type Ca current (I CaL ) was modestly increased in HFpEF rats (−6.60±1.27 versus −5.18±0.75 pA/pF in controls at 0 mV; P<0.05; Figure IB and IC in the onlineonly Data Supplement). The changes all favor prolonged repolarization. A, Optical mapping of control and HFpEF hearts ex vivo showed action potential changes. B, Action potential prolongation in HFpEF is evident in representative recordings. C, Action potential duration at 90% (APD90) is prolonged in HFpEF hearts compared with control hearts. Control rats, n=4; and HFpEF rats, n=4. D, Representative APD map of control and HFpEF hearts. E, APD dispersion was increased in HFpEF rats compared with controls. F, Programmed electric stimulation (PES) in an HFpEF rat elicited polymorphic VT. APD map of the rat heart showed heterogeneous and dispersed APD. G, Activation map analyses of the polymorphic VT showed multiple reentry circuits. The first 10 beats are caused by 10 S1 stimuli and next beat by a single S2. There were ≈22 VT beats with variable clockwise or counterclockwise rotation indicating multiple reentry circuits. Of note, the site of block was found to be located in the region where the APD dispersion was high, and this created the first reentry circuit for the arrhythmia. Error line indicates mean and SD. AU indicates arbitrary unit. *P<0.05. Mixed-model regression with post hoc testing (Tukey adjustment) was used for C, and unpaired t test was used for E. A, Representative action potentials in control and HFpEF cardiomyocytes. B, APD at 90% (APD90) was prolonged in HFpEF cardiomyocytes compared with controls (n=14 cells from 4 control rats, n=7 cells from 4 HFpEF rats). C, Cell capacitance was increased in HFpEF compared with control cardiomyocytes (n=31 cardiomyocytes from control rats, n=38 cardiomyocytes from HFpEF rats). D, F, and H, Representative I to , I Kr , and I K1 recordings in control and HFpEF rats. E, G, and I, Downregulation of I to , I Kr , and I K1 density in HFpEF rats compared with control rats (n=8 cardiomyocytes from n=4 rats in each group). Error line indicates mean and SD (B and C) and SEM (E, G, and I). *P<0.05. **P<0.001. Unpaired t test was used for B; Wilcoxon ranksum test was used for C; and mixed-model regression with post hoc testing (Tukey adjustment) was used for E, G, and I. pA/pF indicates current density calculated from the current amplitude (pA) divided by the membrane capacitance (pF).
ORIGINAL RESEARCH Figure ID and IE in the online-only Data Supplement). This finding indicates that factors other than mean I to density are major contributors to the risk of VA in HFpEF rats.
Quantitative Polymerase Chain Reaction and Western Blot
Concordant with the changes seen in single-cell electrophysiology, the mRNA level of the I to -related potassium channel gene was decreased in HFpEF rat hearts (Kcnd2, P=0.26; Kcnd3, P=0.046; Figure 7A ). In con- Figure 7B and 7C). Kv4.2 expression was similar in the 2 groups ( Figure 7D ), but Kv4.3 expression was decreased in HFpEF (0.32±0.03 versus 0.65±0.07 in controls; P=0.01; Figure 7E ). Kv4.3 is the dominant isoform contributing to I to in rodents. 43 These results are consistent with the notion that downregulation of I to is attributable to decreased not changed between the 2 groups ( Figure IIC -IIF in the online-only Data Supplement).
Fibrosis
The extent of fibrosis, measured with Masson trichrome staining, increased in HFpEF hearts compared with control hearts (9.96±1.29% versus 2.21±0.75% in controls; P<0.001; Figure 7F and 7G). Increased fibrosis favors anatomic reentry and thus contributes to arrhythmogenesis.
DISCUSSION
Here, we have investigated the mechanisms of arrhythmogenesis in HFpEF. Using DSS rats, we found that phenotypically verified HFpEF increases the inducibility of VA by PES as a result of delayed repolarization and multiple reentry circuits (Figure 8 ). In addition to being more frequently inducible, fewer extrastimuli were needed to elicit VA, and VAs lasted longer in HFpEF rats. Although the increase in VA inducibility may be exacerbated by the increase in myocardial fibrosis in this model, 21 we also have discovered that HFpEF is accompanied by abnormal repolarization: surface ECGs showed QTc prolongation; action potentials were prolonged in single-cell recordings; and ex vivo optical mapping revealed increased APD90 and VAs with a torsades-like migratory reentrant pattern. We found prolonged repolarization, downregulation of I to , and reductions in I to -relevant transcript (Kcnd3) and protein (Kv4.3) levels underlying the increased arrhythmic risk. Although some HFpEF rats developed monomorphic VT, 74% exhibited polymorphic VT. Such rats consistently showed multiple reentry circuits by ex vivo optical mapping. This rat model of HFpEF mimics human HFpEF in terms of diastolic dysfunction, QTc prolongation, high sudden death rate, increased fibrosis, and the presence of hypertension as a comorbidity (Table) . In a number of other respects, however, the DSS rat differs from human HFpEF: nonhypertensive comorbidities are absent in the rat, and resting heart rate is not elevated in the disease state. Thus, the data from the HFpEF rat model should be considered hypothesis-generating with respect to arrhythmogenesis in the human condition.
Despite the increasing prevalence of the disease, there has been a lamentable paucity of basic research on HFpEF. For the past decade, the DSS rat has been validated as a reasonable model of HFpEF by different groups. [21] [22] [23] 44, 45 The animals develop diastolic dysfunction after 6 to 7 weeks of an HS diet, along with abnormal relaxation and elevated left ventricular end-diastolic pressure. [21] [22] [23] Concurrently, rats develop HF symptoms, including decreased activity, cachexia, labored breathing, and body edema, starting at 14 weeks of age. 21 Nevertheless, there is some variability in the responses of DSS rats to the HS diet, making it important to confirm the presence of HFpEF echocardiographically and clinically before classifying an animal as having the condition.
Investigating the mechanisms of SCD in animal models is often challenging because of the relatively low incidence of VA and the sudden nature of the disease. Arrhythmias are believed to be the cause of SCD in most cases of HF. 9, 10, 13 Because it is difficult to document the spontaneous development of VA in rats, we applied PES to induce arrhythmias in our experimental model of HFpEF. VA induction by PES has been clinically validated Increased susceptibility to ventricular arrhythmia in heart failure with preserved ejection fraction (HFpEF) is proposed to be caused by action potential prolongation/dispersion and fibrosis, favoring prolonged and heterogeneous repolarization and multiple reentry circuits. The proposed link to sudden cardiac death is plausible but has not been demonstrated by our data. APD indicates action potential duration. 
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to predict the risk of SCD in patients. 29 In our model, HFpEF rats not only were more easily inducible but also had more prolonged VA compared with controls.
Delayed repolarization caused by downregulation of I to has been a recurrent theme in HFrEF animal models and humans. 9, 10, 13 Although I to is considered the major repolarizing current in rat cardiomyocytes, this current is smaller in humans; nevertheless, downregulation of I to has been associated with marked prolongation of action potentials in human HFrEF. 15, 16 Our rat model of HFpEF showed decreased I to and I Kr density, which can potentiate the prolongation of the action potential. Although I Kr is a minor current in rat cardiomyocytes, it plays a crucial role in human cardiac repolarization. Prolongation of the QTc occurs in patients with HFpEF and correlates with the degree of diastolic dysfunction. 46 Furthermore, QTc prolongation is associated with increased mortality in patients with HF and SCD in an older population cohort. 47 , 48 The reasons for delayed repolarization remain unclear. Prolonged APD can theoretically offset systolic failure by prolonging the elevation in activator Ca 2+ during each cardiac cycle, at least in HFrEF. In contrast, the prolongation of repolarization in HFpEF is maladaptive, truncating the time available for ventricular relaxation. In both HFrEF and HFpEF, repolarization delay may favor opportunistic reentry and long-QT-type arrhythmogenesis. We have shown multiple reentrant circuits underlying VA. The combination of prolonged repolarization, increased fibrosis, and inflammation would logically be expected to favor QT dispersion and opportunistic reentry in HFpEF. 21 Furthermore, prolonged repolarization favors the development of afterdepolarizations, which can potentially initiate VA. Therapies targeting these various processes merit further investigation.
Some limitations of the present study should be noted. First, although this HFpEF model has been extensively validated, its relevance to human HFpEF is uncertain, although hypertension is a major comorbidity in human HFpEF. Second, although VA inducibility by PES is not necessarily a reliable surrogate of spontaneous arrhythmias and SCD, this well-controlled intervention can nevertheless provide mechanistic insights that can be tested in the prospective prevention of SCD. Although I to correlated well with underlying transcript and protein levels, the changes in I Kr , I K1 , and the relevant mRNA and proteins were not concordant. Further investigation into the underling mechanisms was beyond the scope of this initial report.
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